Diagnosis | No. of patients |
---|
FTLD-tau (29) | Â |
 Pick’s diseasea
| 18 |
 FTDP-17tau | 1 |
 CBDb
| 4 |
 PSPb
| 4 |
 Unclassifiable | 2, [53] |
FTLD-TDP (32)c
| Â |
 Type A | 4 |
 Type B | 17 |
 Type C | 10 |
 Unclassifiable | 1, [54] |
FTLD-FUS (10) | Â |
 BIBD | 6 |
 NIFID | 2 |
 aFTLD-U | 1 |
 Unclassifiable | 1, [55] |
Unclassifiable (1) | Â |
-
CBD corticobasal degeneration, PSP progressive supranuclear palsy, FTDP-17tau frontotemporal dementia with parkinsonism linked to chromosome 17 associated with tau pathology, BIBD basophilic inclusion body disease, NIFID neuronal intermediate filament inclusion disease; aFTLD-U atypical FTLD with ubiquitinated inclusions
-
aPick’s disease refers to only FTLD-tau with Pick bodies
-
bCases with CBD and PSP were included only if the patients presented with features of FTLD, such as frontotemporal dementia, semantic dementia and progressive nonfluent aphasia
-
cFTLD-TDP cases were classified using the system reported by Mackenzie et al. [56]